BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 12748383)

  • 21. Inhibitory fragment from the p41 form of invariant chain can regulate activity of cysteine cathepsins in antigen presentation.
    Mihelic M; Dobersek A; Guncar G; Turk D
    J Biol Chem; 2008 May; 283(21):14453-60. PubMed ID: 18362148
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Splenic cathepsin L is maturated from the proform by interferon-gamma after immunization with exogenous antigens.
    Zhang T; Maekawa Y; Sakai T; Nakano Y; Ishii K; Hisaeda H; Kominami E; Katunuma N; Asao T; Himeno K
    Biochem Biophys Res Commun; 2001 May; 283(2):499-506. PubMed ID: 11327729
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Endosomal proteolysis and MHC class II function.
    Chapman HA
    Curr Opin Immunol; 1998 Feb; 10(1):93-102. PubMed ID: 9523118
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification and characterization of major histocompatibility complex class II compartments in cortical thymic epithelial cells.
    Arudchelvan Y; Nishimura Y; Tokuda N; Sawada T; Ueyama Y; Fukumoto T
    Anat Rec A Discov Mol Cell Evol Biol; 2003 Sep; 274(1):798-806. PubMed ID: 12923890
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intestinal epithelial cells use two distinct pathways for HLA class II antigen processing.
    Hershberg RM; Framson PE; Cho DH; Lee LY; Kovats S; Beitz J; Blum JS; Nepom GT
    J Clin Invest; 1997 Jul; 100(1):204-15. PubMed ID: 9202073
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression and upregulation of cathepsin S and other early molecules required for antigen presentation in activated hepatic stellate cells upon IFN-gamma treatment.
    Maubach G; Lim MC; Kumar S; Zhuo L
    Biochim Biophys Acta; 2007 Feb; 1773(2):219-31. PubMed ID: 17178165
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regulation of CD1 function and NK1.1(+) T cell selection and maturation by cathepsin S.
    Riese RJ; Shi GP; Villadangos J; Stetson D; Driessen C; Lennon-Dumenil AM; Chu CL; Naumov Y; Behar SM; Ploegh H; Locksley R; Chapman HA
    Immunity; 2001 Dec; 15(6):909-19. PubMed ID: 11754813
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cathepsin S activity regulates antigen presentation and immunity.
    Riese RJ; Mitchell RN; Villadangos JA; Shi GP; Palmer JT; Karp ER; De Sanctis GT; Ploegh HL; Chapman HA
    J Clin Invest; 1998 Jun; 101(11):2351-63. PubMed ID: 9616206
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of cathepsins B, L, S, and D by gastric epithelial cells implicates them as antigen presenting cells in local immune responses.
    Barrera C; Ye G; Espejo R; Gunasena S; Almanza R; Leary J; Crowe S; Ernst P; Reyes VE
    Hum Immunol; 2001 Oct; 62(10):1081-91. PubMed ID: 11600214
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The proteolytic environment involved in MHC class II-restricted antigen presentation can be modulated by the p41 form of invariant chain.
    Fineschi B; Sakaguchi K; Appella E; Miller J
    J Immunol; 1996 Oct; 157(8):3211-5. PubMed ID: 8871612
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of a potent and selective noncovalent cathepsin S inhibitor.
    Thurmond RL; Sun S; Sehon CA; Baker SM; Cai H; Gu Y; Jiang W; Riley JP; Williams KN; Edwards JP; Karlsson L
    J Pharmacol Exp Ther; 2004 Jan; 308(1):268-76. PubMed ID: 14566006
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression of human cathepsin L or human cathepsin V in mouse thymus mediates positive selection of T helper cells in cathepsin L knock-out mice.
    Sevenich L; Hagemann S; Stoeckle C; Tolosa E; Peters C; Reinheckel T
    Biochimie; 2010 Nov; 92(11):1674-80. PubMed ID: 20347002
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Essential role for cathepsin S in MHC class II-associated invariant chain processing and peptide loading.
    Riese RJ; Wolf PR; Brömme D; Natkin LR; Villadangos JA; Ploegh HL; Chapman HA
    Immunity; 1996 Apr; 4(4):357-66. PubMed ID: 8612130
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Class II MHC peptide loading by the professionals.
    Bryant P; Ploegh H
    Curr Opin Immunol; 2004 Feb; 16(1):96-102. PubMed ID: 14734116
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cathepsins B and D are dispensable for major histocompatibility complex class II-mediated antigen presentation.
    Deussing J; Roth W; Saftig P; Peters C; Ploegh HL; Villadangos JA
    Proc Natl Acad Sci U S A; 1998 Apr; 95(8):4516-21. PubMed ID: 9539769
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Destructive proteolysis by cysteine proteases in antigen presentation of ovalbumin.
    Rodriguez GM; Diment S
    Eur J Immunol; 1995 Jul; 25(7):1823-7. PubMed ID: 7621859
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The role of intracellular acidification in antigen processing.
    McCoy KL; Schwartz RH
    Immunol Rev; 1988 Dec; 106():129-47. PubMed ID: 3075587
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Crystal structure of MHC class II-associated p41 Ii fragment bound to cathepsin L reveals the structural basis for differentiation between cathepsins L and S.
    Guncar G; Pungercic G; Klemencic I; Turk V; Turk D
    EMBO J; 1999 Feb; 18(4):793-803. PubMed ID: 10022822
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differential regulation of cathepsin S and cathepsin L in interferon gamma-treated macrophages.
    Beers C; Honey K; Fink S; Forbush K; Rudensky A
    J Exp Med; 2003 Jan; 197(2):169-79. PubMed ID: 12538657
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The p41 isoform of invariant chain is a chaperone for cathepsin L.
    Lennon-Duménil AM; Roberts RA; Valentijn K; Driessen C; Overkleeft HS; Erickson A; Peters PJ; Bikoff E; Ploegh HL; Wolf Bryant P
    EMBO J; 2001 Aug; 20(15):4055-64. PubMed ID: 11483509
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.